Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration

Su-Hyeong Kim1, Anuradha Sehrawat, Kozue Sakao

  • 1Department of Pharmacology and Chemical Biology, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

Plos One
|November 1, 2011
PubMed

Insights

Phenethyl isothiocyanate (PEITC), found in cruciferous vegetables, activates Notch signaling in prostate cells, influencing cancer cell apoptosis and migration. Combining PEITC with Notch inhibitors may enhance its anti-metastatic effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Chemoprevention

Background:

  • Phenethyl isothiocyanate (PEITC) is a cruciferous vegetable compound with demonstrated efficacy against prostate cancer.
  • PEITC's chemopreventive effects are linked to its inhibition of oncogenic pathways like NF-κB, Akt, and androgen receptor.

Purpose of the Study:

  • To investigate the effect of PEITC on Notch signaling in human prostate cancer and normal prostate cells.
  • To elucidate the role of Notch signaling in PEITC-mediated apoptosis and migration inhibition in prostate cancer.

Main Methods:

  • Exposure of prostate cell lines (LNCaP, PC-3, DU145, PrEC) to PEITC.
  • Analysis of Notch1/Notch2 cleavage, transcriptional activity, ligand/receptor expression, and γ-secretase components.
  • Assessment of apoptosis and cell migration using RNA interference and pharmacological inhibitors.
  • In vivo studies using mouse xenografts and TRAMP mice.

Main Results:

  • PEITC treatment activated Notch1 and Notch2 signaling in all tested prostate cell lines.
  • Notch2 played a significant role in mediating PEITC-induced apoptosis and migration inhibition.
  • PEITC-induced anti-metastatic effects were augmented by Notch inhibition.
  • Increased nuclear Notch2 was observed in vivo in PEITC-treated models.

Conclusions:

  • PEITC activates Notch signaling in prostate cells, impacting key cancer processes.
  • Targeting Notch signaling in combination with PEITC may represent a novel strategy for enhancing prostate cancer treatment, particularly for metastasis.
  • The findings suggest a potential therapeutic approach combining PEITC with Notch inhibitors for improved anti-metastatic outcomes.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...